Saeed Yasmeen, Liu Xiaocui
Guangdong Provincial Key Laboratory of Utilization and Conservation of Food and Medicinal Resources in Northern Region, Shaoguan University, Shaoguan City, Guangdong Province, China.
Guangdong VitaLife Biotechnology Co., LTD, Foshan, Guangdong, China.
Int J Reprod Biomed. 2022 Oct 10;20(9):709-722. doi: 10.18502/ijrm.v20i9.12061. eCollection 2022 Sep.
Infertility negatively impacts the overall health and social life of affected individuals and couples. Female infertility is their inability to perceive pregnancy. To date, polycystic ovary syndrome, primary ovarian insufficiency, fallopian tube obstruction, endometriosis, and intrauterine synechiae have been identified as the primary causes of infertility in women. However, despite the mutual efforts of clinicians and research scientists, the development of an effective treatment modality has met little success in combating female infertility. Intriguingly, significant research has demonstrated mesenchymal stem cells as an optimal source for treating infertility disorders. Therefore, here we attempted to capsulize to date available studies to summarize the therapeutic potential of mesenchymal stem cells in combating infertility in women by focusing on the underlying mechanism through which stem cells can reduce the effects of ovarian disorders. Furthermore, we also discussed the preclinical and clinical application of stem cell therapy, their limitation, and the future perspective to minimize these limitations.
不孕症会对受影响的个体和夫妇的整体健康和社会生活产生负面影响。女性不孕症是指她们无法受孕。迄今为止,多囊卵巢综合征、原发性卵巢功能不全、输卵管阻塞、子宫内膜异位症和宫腔粘连已被确定为女性不孕症的主要原因。然而,尽管临床医生和科研人员共同努力,但在开发有效的治疗方法以对抗女性不孕症方面成效甚微。有趣的是,大量研究表明间充质干细胞是治疗不孕症的理想来源。因此,我们在此尝试总结迄今为止的现有研究,通过关注干细胞减少卵巢疾病影响的潜在机制,来概述间充质干细胞在对抗女性不孕症方面的治疗潜力。此外,我们还讨论了干细胞疗法的临床前和临床应用、其局限性以及尽量减少这些局限性的未来前景。